About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
National Health Service
Clinical governance / audit
Commissioning
Community pharmacy
CPD
General management
General practice
Government / regulatory
Health Economics
Healthcare statistics / epidemiology
Hospital trusts
Information provision
IT
Law/ medical ethics/ litigation
Medicines management
National Service Framework
NHS Direct / walk-in
Prescribing and supply of medicines
Primary Care Trusts
Professional bodies
Public Health
All Wales Medicines Strategy Group (AWMSG)
Audit Commission
Clinical Knowledge Summaries (CKS)
Commission for Healthcare Audit & Inspection (CHAI)
Department of Health (DH)
European Agency for the Evaluation of Medicinal Products (EMEA)
Food & Drug Administration (FDA)
Food Standards Agency (FSA)
Health Protection Agency
Health Service Circulars (HSCs)
Kings Fund
Medicines and Healthcare products Regulatory Agency (MHRA)
National Audit Office
National Institute of Clinical Excellence (NICE)
National Patient Safety Agency (NPSA)
National Treatment Agency
NHS Counterfraud Service
Pharmaceutical Services Negotiating Committee (PSNC)
Prodigy (formerly CKS)
Scottish Medicines Consortium
653 library items
in Scottish Medicines Consortium
Filter results by:
Date Published
2012 (7)
2011 (96)
2010 (93)
2009 (80)
2008 (125)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Government / regulatory (
remove
)
,
Scottish Medicines Consortium (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 653
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
SMC does not recommend ranolazine (Ranexa®) as an add-on for stable angina
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
17/01/2012
Category:
2.6.3 Other antianginal drugs
|
Drug reviews
|
Ischaemic heart disease
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
2.
SMC accepts linagliptin film-coated tablet (Trajenta®) for restricted use
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
17/01/2012
Category:
6.1.2 Antidiabetic drugs
|
Diabetes
|
Drug reviews
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
3.
SMC accepts fentanyl single dose nasal spray (Instanyl®) for restricted use
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
17/01/2012
Category:
4.7.2 Opioid analgesics
|
Drug reviews
|
Oncology
|
Pain control
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
4.
SMC accepts once-weekly exenatide (Bydureon®) for restricted use
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
17/01/2012
Category:
6.1.2 Antidiabetic drugs
|
Diabetes
|
Drug reviews
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
5.
SMC accepts erlotinib (Tarceva®) for first-line treatment of patients with advanced NSCLC with EGFR-activating mutations
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
17/01/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: lung
|
Drug reviews
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
6.
SMC does not recommend entecavir (Baraclude®) for chronic hepatitis B in adults with decompensated liver disease
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
17/01/2012
Category:
5.3.3 Viral hepatitis
|
Drug reviews
|
Hepatitis and other gastrointestinal infections
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Drug advice
7.
SMC unable to recommend dexamethasone (Ozurdex ®) intravitreal implant due to absence of submission
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
17/01/2012
Category:
11.4.1 Corticosteroids
|
Drug reviews
|
Ophthalmology
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
8.
SMC unable to recommend denosumab (Xgeva®)
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
12/12/2011
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Bone Diseases
|
Drug reviews
|
Oncology
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
9.
SMC accepts telaprevir (Incivo®) for hepatitis C
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
12/12/2011
Category:
5.3.3 Viral hepatitis
|
Drug reviews
|
Hepatitis and other gastrointestinal infections
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link (previously treated)
Link (treatment-naive)
10.
SMC does not recommend dexamethasone intravitreal implant (Ozurdex®) for macular oedema following retinal vein occlusion
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
12/12/2011
Category:
11.4.1 Corticosteroids
|
Drug reviews
|
Ophthalmology
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
Results 1 - 10 of 653
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next